SG10201706208SA - Immunomodulatory Agent and Uses Therefor - Google Patents
Immunomodulatory Agent and Uses ThereforInfo
- Publication number
- SG10201706208SA SG10201706208SA SG10201706208SA SG10201706208SA SG10201706208SA SG 10201706208S A SG10201706208S A SG 10201706208SA SG 10201706208S A SG10201706208S A SG 10201706208SA SG 10201706208S A SG10201706208S A SG 10201706208SA SG 10201706208S A SG10201706208S A SG 10201706208SA
- Authority
- SG
- Singapore
- Prior art keywords
- immunomodulatory agent
- uses therefor
- therefor
- immunomodulatory
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012901189A AU2012901189A0 (en) | 2012-03-23 | Immunomodulatory agents and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201706208SA true SG10201706208SA (en) | 2017-08-30 |
Family
ID=49221713
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201706208SA SG10201706208SA (en) | 2012-03-23 | 2013-03-25 | Immunomodulatory Agent and Uses Therefor |
| SG11201405848UA SG11201405848UA (en) | 2012-03-23 | 2013-03-25 | Immunomodulatory agent and uses therefor |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201405848UA SG11201405848UA (en) | 2012-03-23 | 2013-03-25 | Immunomodulatory agent and uses therefor |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20150216955A1 (fr) |
| EP (1) | EP2827890B1 (fr) |
| JP (2) | JP2015512371A (fr) |
| KR (1) | KR20150010716A (fr) |
| CN (2) | CN104519907A (fr) |
| AU (1) | AU2013234815B2 (fr) |
| BR (1) | BR112014023572A2 (fr) |
| CA (1) | CA2868123A1 (fr) |
| CL (1) | CL2014002522A1 (fr) |
| EA (1) | EA201491748A1 (fr) |
| IL (1) | IL234756A0 (fr) |
| MX (1) | MX2014011488A (fr) |
| MY (1) | MY172706A (fr) |
| NZ (1) | NZ631340A (fr) |
| PH (1) | PH12014502063A1 (fr) |
| SG (2) | SG10201706208SA (fr) |
| WO (1) | WO2013138871A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012082803A2 (fr) | 2010-12-13 | 2012-06-21 | Cel-Sci Corporation | Procédé pour induire une réponse immunitaire contre les virus de la grippe aviaire, porcine, espagnole, h1n1, h5n9 et leurs formulations |
| US10179174B2 (en) | 2011-05-25 | 2019-01-15 | Cel-Sci Corp. | Method for inducing an immune response and formulations thereof |
| WO2012162565A2 (fr) | 2011-05-25 | 2012-11-29 | Cel-Sci Corporation | Procédé d'induction d'une réponse immunitaire dans le traitement du cancer et de maladies ou de pathologies auto-immunes |
| CN109771444A (zh) * | 2019-04-03 | 2019-05-21 | 哈尔滨北极神生物工程有限公司 | 蜂胶氨糖人参皂甙复合胶囊及制备方法 |
| US20220218806A1 (en) * | 2019-05-11 | 2022-07-14 | CRL-SCI Corporation | Peptides and conjugates for treatment of arthritis |
| CN115515614A (zh) * | 2020-02-06 | 2022-12-23 | 尤尼根公司 | 用于改进关节健康和治疗关节炎的包含山姜属和其它植物提取物的组合物 |
| CN112675299B (zh) * | 2021-01-06 | 2023-10-20 | 黑龙江省百洲生物工程有限公司 | 一种防控鹅星状病毒复合佐剂灭活疫苗的制备方法 |
| WO2024057793A1 (fr) * | 2022-09-13 | 2024-03-21 | 国立大学法人信州大学 | Peptide citrulliné pour la suppression de la métastase cancéreuse |
| WO2024077071A2 (fr) * | 2022-10-05 | 2024-04-11 | The Johns Hopkins University | Nanoparticules pour l'administration de matériaux immunorégulateurs à des cellules t |
| CN117085118A (zh) * | 2023-08-22 | 2023-11-21 | 北京大学人民医院 | 一种瓜氨酸化ii型胶原多肽疫苗及其应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4631211A (en) | 1985-03-25 | 1986-12-23 | Scripps Clinic & Research Foundation | Means for sequential solid phase organic synthesis and methods using the same |
| JPH03504975A (ja) | 1988-06-14 | 1991-10-31 | セル―エスシーアイ コーポレイション | 異種官能性細胞免疫剤、それを含有するワクチン及びその使用方法 |
| US6106840A (en) | 1988-06-23 | 2000-08-22 | Anergen, Inc. | MHC conjugates useful in ameliorating autoimmunity |
| FI87028C (fi) | 1989-12-22 | 1992-11-10 | Nokia Mobile Phones Ltd | Metod foer att reglera effekt hos en spaenningsstyrd effektfoerstaerkare och koppling foer anvaendning i metoden |
| US5139749A (en) | 1990-06-22 | 1992-08-18 | Tas, Inc. | Fluidized calcining process |
| PT98990A (pt) | 1990-09-19 | 1992-08-31 | American Home Prod | Processo para a preparacao de esteres de acidos carboxilicos de rapamicina |
| ZA935112B (en) | 1992-07-17 | 1994-02-08 | Smithkline Beecham Corp | Rapamycin derivatives |
| US5234140A (en) | 1992-07-28 | 1993-08-10 | S. C. Johnson & Son, Inc. | Re-useable aerosol container |
| US5817308A (en) | 1994-02-14 | 1998-10-06 | University Of Rochester | Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
| MY129435A (en) | 1994-10-26 | 2007-04-30 | Novartis Ag | Pharmaceutical microemulsion preconcentrates |
| CA2251781A1 (fr) | 1996-03-20 | 1997-09-25 | Charles Nicolette | Methode d'identification d'epitopes de lymphocytes t cytotoxiques |
| GB9612629D0 (en) | 1996-06-17 | 1996-08-21 | Oxford Biosciences Ltd | Method for providing dense particle compositions for use in transdermal particle delivery |
| EP0937082A2 (fr) | 1996-07-12 | 1999-08-25 | Ariad Pharmaceuticals, Inc. | Elements et procedes pour traiter ou prevenir les mycoses pathog nes |
| US6432963B1 (en) | 1997-12-15 | 2002-08-13 | Yamanouchi Pharmaceutical Co., Ltd. | Pyrimidine-5-carboxamide derivatives |
| WO2001014387A1 (fr) | 1999-08-24 | 2001-03-01 | Ariad Gene Therapeutics, Inc. | Analogues d'epirapamycine-28 |
| BR0109455A (pt) * | 2000-03-23 | 2003-06-03 | Akzo Nobel Nv | Uso de mia e/ou seus fragmentos, método para tratar mamìferos sofrendo de, ou susceptìvel a, uma doença inflamatória, peptìdeo, composição farmacêutica, e, uso dos peptìdeos |
| CN100522967C (zh) | 2002-02-01 | 2009-08-05 | 阿里亚德基因治疗公司 | 含磷化合物及其应用 |
| TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| US20030235610A1 (en) * | 2002-06-21 | 2003-12-25 | Piedmont Pharmaceuticals, Llc | Liposomes containing biologically active compounds |
| CA2421321A1 (fr) | 2003-03-07 | 2004-09-07 | London Health Sciences Centre Research Inc. | Peptides associes a la molecule hla-dr de cmh de classe ii et intervenant dans l'arthrite rhumatoide |
| US7160867B2 (en) | 2003-05-16 | 2007-01-09 | Isotechnika, Inc. | Rapamycin carbohydrate derivatives |
| US7220755B2 (en) | 2003-11-12 | 2007-05-22 | Biosensors International Group, Ltd. | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
| EP3590503A1 (fr) * | 2006-10-12 | 2020-01-08 | The University of Queensland | Compositions et procédés pour moduler les réponses immunologiques |
| EP2254588B1 (fr) | 2008-03-14 | 2017-10-11 | Cel-Sci Corporation | Procédés de préparation et composition de constructions de peptide utiles pour le traitement de la polyarthrite rhumatoïde |
| JPWO2009116246A1 (ja) | 2008-03-17 | 2011-07-21 | パナソニック株式会社 | 通信方法、通信システム、モバイルノード及びアクセスルータ |
| US9063148B2 (en) | 2008-10-22 | 2015-06-23 | The Henry M. Jackson Foundation For The Advancement Of Military Medicince, Inc. | Immunoassays for citrullinated proteins |
| CA2765534C (fr) | 2009-06-15 | 2018-09-18 | Rigel Pharmaceuticals, Inc. | Inhibiteurs a petite molecule de la tyrosine kinase de la rate (syk) |
| US9975944B2 (en) * | 2013-03-12 | 2018-05-22 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Synthetic peptides for the treatment of autoimmune diseases |
| IL303425A (en) * | 2013-03-13 | 2023-08-01 | Cour Pharmaceuticals Dev Company | Secondary vaccine particles for the treatment of inflammation |
| EP2989121B1 (fr) * | 2013-04-26 | 2020-10-07 | Cel-Sci Corporation | Méthodes de préparation et composition de constructions peptidiques utiles pour le traitement de la polyarthrite rhumatoïde |
-
2013
- 2013-03-25 SG SG10201706208SA patent/SG10201706208SA/en unknown
- 2013-03-25 NZ NZ631340A patent/NZ631340A/en not_active IP Right Cessation
- 2013-03-25 CN CN201380027092.6A patent/CN104519907A/zh active Pending
- 2013-03-25 CA CA2868123A patent/CA2868123A1/fr not_active Abandoned
- 2013-03-25 AU AU2013234815A patent/AU2013234815B2/en not_active Ceased
- 2013-03-25 KR KR1020147029837A patent/KR20150010716A/ko not_active Application Discontinuation
- 2013-03-25 EA EA201491748A patent/EA201491748A1/ru unknown
- 2013-03-25 BR BR112014023572A patent/BR112014023572A2/pt not_active IP Right Cessation
- 2013-03-25 WO PCT/AU2013/000303 patent/WO2013138871A1/fr active Application Filing
- 2013-03-25 SG SG11201405848UA patent/SG11201405848UA/en unknown
- 2013-03-25 US US14/387,529 patent/US20150216955A1/en not_active Abandoned
- 2013-03-25 CN CN201910675625.0A patent/CN110404062A/zh active Pending
- 2013-03-25 MX MX2014011488A patent/MX2014011488A/es unknown
- 2013-03-25 MY MYPI2014702673A patent/MY172706A/en unknown
- 2013-03-25 EP EP13764426.6A patent/EP2827890B1/fr active Active
- 2013-03-25 JP JP2015500718A patent/JP2015512371A/ja active Pending
-
2014
- 2014-09-17 PH PH12014502063A patent/PH12014502063A1/en unknown
- 2014-09-21 IL IL234756A patent/IL234756A0/en unknown
- 2014-09-23 CL CL2014002522A patent/CL2014002522A1/es unknown
-
2019
- 2019-01-17 JP JP2019006439A patent/JP2019070034A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201405848UA (en) | 2014-10-30 |
| AU2013234815B2 (en) | 2017-06-22 |
| NZ631340A (en) | 2016-11-25 |
| CL2014002522A1 (es) | 2015-06-12 |
| WO2013138871A1 (fr) | 2013-09-26 |
| CN104519907A (zh) | 2015-04-15 |
| MY172706A (en) | 2019-12-11 |
| CA2868123A1 (fr) | 2013-09-26 |
| EA201491748A1 (ru) | 2015-02-27 |
| PH12014502063A1 (en) | 2014-12-10 |
| BR112014023572A2 (pt) | 2017-09-12 |
| AU2013234815A1 (en) | 2014-10-09 |
| JP2015512371A (ja) | 2015-04-27 |
| EP2827890A1 (fr) | 2015-01-28 |
| KR20150010716A (ko) | 2015-01-28 |
| EP2827890B1 (fr) | 2019-08-28 |
| MX2014011488A (es) | 2015-05-11 |
| JP2019070034A (ja) | 2019-05-09 |
| EP2827890A4 (fr) | 2015-11-25 |
| CN110404062A (zh) | 2019-11-05 |
| IL234756A0 (en) | 2014-11-30 |
| US20150216955A1 (en) | 2015-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1199023A1 (en) | Substituted benzothienylpyrrolotriazines and uses thereof | |
| HK1202545A1 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| HK1200822A1 (en) | Substituted dipyridylamines and uses thereof | |
| IL237309A0 (en) | Benzocyclooctyne compounds and uses thereof | |
| EP2829480A4 (fr) | Dispositif d'alimentation en médicament et dispositif de comptage de médicament | |
| EP2827029A4 (fr) | Dispositif d'étanchéité et structure d'étanchéité | |
| EP2884135A4 (fr) | Thermorégulateur et composant de thermorégulateur | |
| HK1210949A1 (en) | Combinations and uses thereof | |
| IL234756A0 (en) | A preparation for regulating the immune system and its uses | |
| ZA201501124B (en) | Trans-clomiphene formulations and uses thereof | |
| GB201216649D0 (en) | Agents and methods | |
| AP2014007869A0 (en) | Substituted phenylimidazopyrazoles and use thereof | |
| HK1210809A1 (en) | Beta-hexosyl-transferases and uses thereof | |
| GB201214729D0 (en) | Communicating assembly and apparatus | |
| HK1207154A1 (en) | C1q-adiponectin complex and use thereof c1q- | |
| SI2830587T1 (sl) | Sestavek za zaščito in uravnoteženje kože | |
| GB201210989D0 (en) | Composition and device | |
| EP2922862A4 (fr) | Agents de formation-modulation de complexes et leurs utilisations | |
| AU2012901189A0 (en) | Immunomodulatory agents and uses therefor | |
| GB201222541D0 (en) | Kiddibidet and pottibidet | |
| IL218974A0 (en) | Conaction bitwen coutch and playels | |
| GB201202021D0 (en) | Co-sleeper and breastfeeder | |
| GB201222342D0 (en) | Compounds and uses thereof |